Ann: Bodyguard Results, page-98

First 98 Last

Share
Profile

Follow
Padlock

5,988 Posts.

424

23/02/16

13:51

Post #: 17093061
Share
Originally posted by Charles89 ↑

Just going through the numbers provided about the participants:

Best product ever tried - 3 in 10 - 30%

Would definitely buy - 1 in 4 - 25%

4/5 star user experience - 51 in 100 - 51%

3 star user experience - 1 in 3 - 33.33%

I think from the numbers above, we can confirm that:

BG can definitely capture a minimum of 25% market share

84.33% of participants rates the user experience 50% or higher

15.67% rated the user experience 1-2 stars

While here are other things to consider (not facts but just educated guess):

49% of people may have rated 1-3 starts because of skin irritations

Due to "higher skin irritation levels", it may be the reasons why some of the 70% people may not definitely buy BG (100%-30% - best product ever tried), but since that problem is now eliminated "with the adoption of a new Hydrogen gel technology", we may be able to capture more participant to buy BG

If before the skin irritation issue was fixed, BG can capture 25% people, then if we get rid of the skin irritations, BG may be able to capture a further 25% of the 75% that won't definitely not buy BG. So together with the original 25% and 25% of 75%, equals 42.5% that could definitely buy BG.

And if skin irritation is another factor that caused a bad user experience, we may be able to convert roughly half of them them to a 4-5 star after it's fixed, which will roughly give a 75% to a 4/5 stars user experience. OR maybe roughly 90% to a 3+ stars experience.

I think the stats would look much more appealing once BG fixes the skin irritation side of things, while "further enhance efficacy of Kneeguard."

Expand

more than one in four claim they would definitely buy the starter kit....
OBJ Price at posting: 6.9¢ Sentiment: None Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

Failure to report prompts ASX to impose multiple company suspensions

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

LU7

Strong PFS numbers solidify Lithium Universe's big plans for Québec

IRE

Iress runs 'hot' for Wealth Within's stock tips

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 113 more messages in this thread...

First 98 Last

Add WFL (ASX) to my watchlist

(20min delay)
Last 0.3¢		Change 0.000(0.00%)		Mkt cap ! $1.478M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Ann: Bodyguard Results, page-98

Failure to report prompts ASX to impose multiple company suspensions

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Iress runs 'hot' for Wealth Within's stock tips

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Featured News

Ann: Bodyguard Results, page-98

Top Stories

Failure to report prompts ASX to impose multiple company suspensions

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Iress runs 'hot' for Wealth Within's stock tips

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Featured News